Study of COVID-19 in hospitalized children
Part of Infections, Lungs & breathing clinical trials.
This study looks at children (ages 0 to 18) who are in the hospital with suspected COVID-19. It aims to understand what factors affect outcomes and how the immune system responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 0 to 18 years old
- Be currently hospitalized with suspected COVID-19
- You are being evaluated for COVID-19 because clinicians suspect it
- Not be older than 18 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
This study looks at what health problems remain after a person was hospitalized for COVID-19. It may help doctors understand these long-lasting effects and how to care for people afterward.
This trial is studying children who are very sick from COVID-19 or have a related condition called MIS-C. It aims to understand how severe COVID-19 affects children and improve care.
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
This study looks at children hospitalized with bronchiolitis (a lung infection that causes coughing and breathing trouble). It aims to understand what makes some children more likely to get very sick. By joining, researchers can learn more about risk factors and how to help children recover better.
Hear when a new Pediatric Respiratory Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.